Physician profile
James D Sutton
NPI 1336252774
$2,771.54
in general payments reported to CMS, 2019-2025
14 companies · $528 in 2025
The $528 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $365 · 2020: $296 · 2021: $380 · 2022: $287 · 2023: $407 · 2024: $508 · 2025: $528.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,195 · Long Term Medical Supply Or Device Loan: $150 · Education: $97.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,195.35 |
| Long Term Medical Supply Or Device Loan | $150.00 |
| Education | $97.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,010.51 | 2019-2025 | Clareon, Unity, Rocklatan |
| Abbvie INC. | $374.59 | 2022-2025 | Durysta |
| Carl Zeiss Meditec USA, INC. | $197.60 | 2021 | |
| Eyevance Pharmaceuticals LLC | $182.30 | 2020-2022 | |
| Ocular Therapeutix, INC. | $175.21 | 2023 | Dextenza |
| Sun Pharmaceutical Industries INC. | $170.11 | 2020-2022 | |
| Omeros Corporation | $150.18 | 2019-2020 | |
| Rxsight INC | $142.81 | 2024 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Rxsight Contact Lens |
| Allergan, INC. | $139.85 | 2021-2022 | |
| Mallinckrodt Hospital Products INC. | $122.22 | 2024 | Acthar |
| Halozyme INC | $30.47 | 2019 | |
| Carl Zeiss Meditec, INC. | $29.98 | 2020 | |
| Oyster Point Pharma, INC. | $25.30 | 2022 | |
| Bausch & Lomb Americas INC. | $20.41 | 2024 | Miebo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Sutton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.